Bibliografía del artículo
1. Jey V. This month in history Paul Langerhans. Journal of Royal Society of Medicine 92:59, 1999.
2. Silberbeg I, Silberberg MD, Alfred W, Kopf MD, Cooper WS. J Investi Dermatol 47:87-98, 1996.
3. Ardavin C, Martínez del Hoyo G, Martín P, Anjuere F, Arias CF, Marín AR, Ruiz S, Parrillas V, Hernández H. Origin and differentiation of dendritic cells. Trends in Immunology 22(12):691-700, 2001.
4. Reid CD, Fryer PR, Claifford C, et al. Identification of hematopoietic progenitor of macrophages and dendritic langerhans cells (DL-CFU) in human bone marrow and periphereal blood. Blood 76:1139-1149, 1990.
5. Makala LH, Nagasawa H. dendritic cells an specialized complex system of antigen presenting cells. J Vet Med Sci 64:181-193, 2002.
6. Wright-Browne U, McClaim KL, Talpaz M, Ordoñez N, Estrow Z. Physiology and pathofisiology of dendritic cells. Human Pathol 28:563-579, 1997.
7. Diumenjo MS, Rivero MG. Células dendríticas: más que una célula presentadora de antígenos. Enfoques 2(5):1-3, 2004.
8. Chuluyan HE, Jancic CC, Lutzky VP, Zittermon SI, Mffei P, et al. Células dendríticas: las células presentadoras de Antígeno más eficientes implicadas en inmunoterapia. Ultimos Avances en Inmunobiología, Inmunogenética y Transplante 77-82, 2005.
9. Eriksson K, Ahifors E, George-Chandy, A, Kaiserlian D, Czerzinsky C. Antigen presentation in the murine oral epithelium. Immunology 88:147-152, 1996.
10. Kosko-Vilbois MH. Follicular dendritic cells molecules associated with function. In: Dendritic cells. 2nd ed Lotze MT, Thomson AW editor San Diego Academia Press. pp 29-34, 2001.
11. Cuttler CW, Jotwani R. Dendritic cells at the oral mucosal interface. JDR 85(8):678-689, 2006.
12. Steiman RM, Bhardway N. Dendritic cells In: Gallin JI, Syderman R. Inflammation: Basic principles. Clinical correlates. 3rd ed., Lippincott Williams & Wilkins, Filadelfia pp. 49-53, 1999.
13. Abbas AK, Lichtman AH. Procesamiento antigénico y presentación de los linfocitos T. En: Inmunología celular y molecular, 5ª ed. Elservier, Madrid pp. 81-104, 2003.
14. Barclay AN, Birkeland ML, Brown MH, Beyers AD, Davis SJ, Somoza C, Willians AF (Eds). Leukocite antigens facts book, 2ª ed. Academic Press, Nueva York, 1997.
15. Bancherau J. Células dendríticas. Investig y Ciencia 24-3, 2003.
16. Baumgart DC, Metzke D, Schmitz J, Schefold A, Sturm A, Wiedemann B et al. Patients with active inflammatory bowel disease lack inmature periphereal blood plasmacytoid and myeloid dendritic cells. Gut 54:228-236, 2005.
17. Gilliet Eliu YJ. Generation of human CD8T regulatory cells by CD40 ligand activated plasmocytoid dendritic cells. J Exp Med 195:388-393, 2002.
18. Allan JP, Novac N, Fuchs C, Asen S, Berge S, Appel T, et al. Characterization of dendritic cells from human oral mucosa a new Langerhans cells type with high constitutive Fc epsilonRI expression. J Allergy Clin Immunol 112:141-148, 2003.
19. Peiser M, Grutzkau A, Wanner R, Kolde G. CD1a and CD1c cell sorting yields an homogeneous population of immature human Langerhans cells. J Immunol Methods, 2003.
20. Caux C, Dezutter-Dambuyant C, Schmith D, Bancherau J. GM-CSF and TNF alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258-261, 1992.
21. Datta SK, Redecke V, Prilliman KR, Takabayashi K, Corr M, Tailant Tet al. A subset of Toll-like receptors ligands induces cross-presentation by bone marrow derived dendritic cells. J Immunol 170:4102-4110, 2003.
22. Kadowaki N, Antonenko S, Kastelein RA, Bazán F et al. Subsets of human dendritic cell precursors Express different Toll-like receptors and respond to different microbial antigens. J Exp Med 194:863-869, 2001.
23. Kopp E, Medzhitov R. recognition of microbial infection by Toll-like receptors. Curr Opin Immunol 15:396-401, 2003.
24. Mowat AM, Parker LA, Beacock-Sharp H, Millington OR, Chardo F.Oral tolerance overview and historical perspectivas.Ann NY Acad Sci 1029:1-8, 2004.
25. Irribaren P, Correa SG. Participación de las células dendríticas en la inducción de tolerancia inmunológica. En: Rabinovich AG. Inmunopatología molecular. Edit. Panamericana pp. 450-457, 2004.
26. Williamson E, Bisborough JM, Viney JL. Regulation of mucosal dendritic cell function by receptor activator of NK-kappaB (RANK/RANK ligand interactions impact of tolerance induction. J Immunol 169:3606-3612, 2002.
27- Van Wilsen EJ, Van Hoogstraten IM, Breve J, Scheper RJ, Kraal G. Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair. Immunology 83:128-132, 1994..
28. Abbas AK, Lichtman AH. Sistema inmunitario cutáneo. En: Inmunología celular y molecular, 5ª ed. Elservier, Madrid pp. 32-39, 2003.
29. Hasseus B, Jontell M, Bergenholtz G, Eklund C, Dahigren UI. Langerhans cells from human oral epitheliumare more effective at stimulating allogenic T cells in vitro than Langerhans cells from skin epithelium. J Dent Res 78:751-758, 1999.
30. Brandtzaeg P. Overview of the mucosal immune system. Curr Top Microbiol Immunol 146-13, 1989.
31. Romero MD, Vucovich PR, Rabinovich GA. Sistema immune de mucosas ¿barrera o puerta de entrada de antígenos ambientales? En: Rabinovich GA. Inmunopatología molecular. Edit. Panamericana. Buenos Aires, pp. 165-176, 2004.
32. Pulendran B, Smith JL, Caspary G, Brasel K, Petit D, Marakosvky E, et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proa Natl Acad Sci USA 96:1036-1041, 1999.
33. Puledran B, Maraskovsky E, Banchearau J, Maliszewski C. Modulating the immune response with dendritic cells and their grow factors. Trends in Immunology 2281:41-46, 2001.
34. Aroonerau N, Pichyangkul S, Yongvanitcht K, Wisentchag M et al. Generation of Porphyromonas gingivalis pulsed dendritic cells from periodontitis patients. J Periodontal Res 38:262-268, 2003.
35. Cutler CW, Jotwani R, Palucka KA, Daroust J, Bell D, Bancherau J. Evidence and a novel hypothesis for the role of dendritic cells and P. gingivalis in adult peridodontitis. J Periodontal Res 43:406-412, 1999.
36. Williamson E, Bisborough JM, Viney JL. Regulation of mucosal dendritic cell function by receptor activator of NF-kappaB (RANK) RANK ligand interactions impact on tolerance induction. J Immunol 169:3600-3612, 2002.
37. Gerosa F, Baldani-Guerra B, Nissi C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interactions between Natural Killer cells and dendritic cells. Exp Med 195(3):327-333, 2002.
38. Walton LJ, Macey MG, Thornhill MH, Farthing PM. Intra-epithelial subpopulations of T lymphocytes and langerhans cell in oral lichen planus. J Oral Pathol Med 27:116-123, 1998.
39. Santoro A, Majorana A, Roversi L, Gentili F, Marrelli S, Vermi W, et al. Recruitment od dendritic cells in oral liquen planus. J Pathol 205:426-434, 2005.
40. Mc Cartan BE, Lamey PJ. Expression of CD1 and HLA-DR by Langerhans cells (LC) in oral lichenoid drug eruptions and idiophatic oral lichen planus (LP). J Oral Pathol Med 26:176-180, 1997.
41. Jotwani R, Pulendran B, Agrawal S, Cuttler CW. Human dendritic cells respond to Porphyromonas gingivalis LPS by promoting Th2 effector response in vitro. Eur J Immunol 33:2980-2986, 2003.
42. Gemmel E, Carter CL, Hart DN, Drysdale KE, Seymour GJ. Antigen-presenting cells in human periodontal disease tissues. Oral Microbiol Immunol 17:388-393, 2002.
43. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J. Liu YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 185:1101-1111, 1997.
44. Newcomb GM, Seymour GJ, Powell RN. Association between plaque accumulation and Langerhans cell numbers in the oral epithelium of attached gingiva. J Clin Periodontal 9:297-304, 1982.
45. Mahanonda R, Sa-Ard-Iam N, Yongvanitchit K, Wisetchang M. Ishikawa I, Nagasawa T, et al. Upregulation of co-stimulatory molecule expression and dendritic cell marker (CD83) on B cells in periodontal disease. J Periodontal Res 37:177-183, 2002.
46. Rivolier A, Mazzorana M, Tebib J, Piperno M, Artsiselm T, Rabourdin-Combe C et al. Immature dendritic cells transdiferentiation into osteoclast. A novel pathway sustained by the rheumatoid artritis microenvironment cell differentiation. Blood 104:4029-4037, 2004.
47. Coronato S, Laguens GE, Spinelli OM, Salas MA, Di Girolamo W. Células dendríticas y su papel en patología. Medicina 58:209-218, 1998.
48. Fon GL, Engelman EG. DC in cancer immunotherapy. Annual review of Immunology 18:245-273, 2000.
49. Gabrilovich DI, Chen HL, Girgis KR, et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2:1096-1103, 1992.
50. Wang ZY, Li SW, Hu QG, Tian WD. Immunohistochemical analysis of dendritic cell in oral squamous cell carcinoma. Hua Xi Kou Qiang Yi Xue Za Zhi 22:103-105, 2004.